Quick Facts on MDS Inc:
-
MDS is a $1.1 billion pure-play global life sciences company that provides market-leading products and services used for the development of drugs and the diagnosis and treatment of disease.
-
MDS is a publicly traded company on the TSX and NYSE.
-
MDS has 5,500 highly skilled employees operating in 29 countries, and distributes products to 62 countries.
-
MDS has a focused set of businesses with leading positions in life sciences markets. MDS businesses include: MDS Analytical Technologies (analytical instruments), MDS Nordion (molecular imaging) and MDS Pharma Services (contract research).
-
MDS customers are the most prestigious researchers in pharmaceutical, biotechnology, government, and academic institutions around the world.
-
In 2007 MDS completed the largest divestiture (MDS Diagnostic Services) and the largest acquisition (Molecular Devices Corporation) in the Company's history and returned value to shareholders through a $500 million share buyback.
-
In 2007, net revenues for MDS were up 17% to US$1.1 billion, adjusted EBITDA was up 88%, and adjusted earnings per share doubled.
-
MDS had a strong start to 2008 with double-digit growth in both net revenues and profitability in Q1 – net revenues were up 23% to $296 million, adjusted EBITDA up 33% to $40 million.
- MDS has a strong balance sheet and a management team with a proven track record of successful execution.
Find out more about what our business units do and their market opportunities in our MDS Snapshots. |